Results 191 to 200 of about 480,371 (358)

Machine learning methods for predicting adverse drug events: A systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Predicting adverse drug events (ADEs) in outpatient settings is crucial for improving medication safety, identifying high‐risk patients and reducing health‐care costs. While traditional methods struggle with the complexity of health‐care data, machine learning (ML) models offer improved prediction capabilities; however, their effectiveness in ...
Niaz Chalabianloo, Fatemeh Ahmadi, Mohammad Ali Omrani, Sheikh S. Abdullah, Neda Rostamzadeh, Atefeh Jafari, Lujain Izzedin, Kamran Sedig, Flory T. Muanda   +8 more
wiley   +1 more source

Percutaneous Ablation of Thyroid Cancer. [PDF]

Radiol Imaging Cancer
Huber TC, Walker L, Wilkins L.
europepmc   +1 more source

Expression of ANGPTL2 and its impact on papillary thyroid cancer [PDF]

, 2019
Longyan Yang, Rongxin Sun, Yan Wang, Ying Fu, Yuanyuan Zhang, Zhaohui Zheng, Zhili Ji, Dong Zhao   +7 more
openalex   +1 more source

Mitigating subtherapeutic cabozantinib exposure after prior mitotane therapy in adrenocortical carcinoma: Pharmacological boosting with cobicistat

British Journal of Clinical Pharmacology, EarlyView.
Mitotane is an adrenolytic drug with cytotoxic effects, registered for the treatment of advanced adrenocortical carcinoma (ACC), a rare but aggressive tumour type with a poor prognosis despite treatment. Recently, the oral multi‐kinase inhibitor cabozantinib has shown promising results as a potential second‐line treatment option.
Annemieke M. Peters van Ton, Nielka P. van Erp, Annenienke C. van de Ven, Janneke E. W. Walraven, Loek A. W. de Jong   +4 more
wiley   +1 more source

Thyroid Cancer and Physical Activity: A Bibliometric Analysis. [PDF]

J Multidiscip Healthc
Dong B, Xiao S, Zhang W, Wang Y.
europepmc   +1 more source

Knowledge, Awareness and Perception towards Thyroid Cancer in General Population: A Systematic Review

, 2023
Yongjin Li, Li Wang, Jianfeng Ni, Jiali Gu   +3 more
openalex   +1 more source

MAPK13 promotes the progression of papillary thyroid cancer. [PDF]

Eur Thyroid J
Zhao R, Su Z, Wan Z, Qiao P, Lu Y, Chi Y, Zheng L, Zhang Y, Huang S, Chen X.   +9 more
europepmc   +1 more source

Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer [PDF]

, 2016
Lisa Zhang, Myriem Boufraqech, Ross Lake, Electron Kebebew   +3 more
openalex   +1 more source

Special Issue "Molecular Biology of the Thyroid Cancer and Thyroid Dysfunctions". [PDF]

Int J Mol Sci
Vija L.
europepmc   +1 more source

X‐ray controlled release strategy in cancer therapy

BMEMat, EarlyView.
A comprehensive review on the design principles and current strategies of X‐ray stimulated release systems in cancer therapy, focusing on the X‐ray responsive functional groups and materials as well as discussing the advantages and current challenges of X‐ray controlled release systems in cancer therapy.
Yiling Ruan, Hongxiang Huang, Huihui Liu, Jinglang Gong, Changjun Li, Xiaolian Sun   +5 more
wiley   +1 more source